ATP wants vaccine maker to cool use of warrants in reward schemes

The Danish vaccine maker’s warrant use has jumped 71% since 2020.
Claus Berner Møller, vice president for Danish Equities at ATP (right) and Claus Wiinblad, senior vice president for Danish equities | Photo: Stine Bidstrup
Claus Berner Møller, vice president for Danish Equities at ATP (right) and Claus Wiinblad, senior vice president for Danish equities | Photo: Stine Bidstrup
by marketwire, translated by daniel pedersen

A major shareholder in Bavarian Nordic, Danish state pension fund ATP, wants to put a stop to the Danish vaccine makers habit of using warrants, which has increased 71% from 2020 to DKK 3.65m (USD 534m), reports Danish business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading